Ligand validation:6YLT

P3E: [[(2~{R},3~{S},4~{R},5~{R})-5-[2-azanyl-7-[(3-methylphenyl)methyl]-6-oxidanylidene-1~{H}-purin-9-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] [[(2~{R},3~{S},4~{R},5~{R})-5-(2-azanyl-6-oxidanylidene-1~{H}-purin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] hydrogen phosphate

P3E is a Ligand Of Interest in 6YLT designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6YLT_P3E_A_300	20%	13%	0.256	0.86	1.8	2.29	12	18	2	0	100%	0.554
6YLT_P3E_B_300	16%	13%	0.256	0.827	1.9	2.28	13	16	2	0	100%	0.636
6YLT_P3E_D_300	6%	17%	0.281	0.777	1.88	1.94	9	9	1	0	68%	0.2678
6YLT_P3E_C_300	5%	17%	0.259	0.721	1.83	1.92	8	12	2	0	68%	0.678

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.